相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Introducing RpsA Point Mutations Δ438A and D123A into the Chromosome of Mycobacterium tuberculosis Confirms Their Role in Causing Resistance to Pyrazinamide
Wanliang Shi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
In Vivo-Selected Pyrazinoic Acid-Resistant Mycobacterium tuberculosis Strains Harbor Missense Mutations in the Aspartate Decarboxylase PanD and the Unfoldase CIpC1
Pooja Gopal et al.
ACS INFECTIOUS DISEASES (2017)
Pyrazinoic Acid Inhibits Mycobacterial Coenzyme A Biosynthesis by Binding to Aspartate Decarboxylase PanD
Pooja Gopal et al.
ACS INFECTIOUS DISEASES (2017)
Polder maps: improving OMIT maps by excluding bulk solvent
Dorothee Liebschner et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2017)
Anti-tubercular Activity of Pyrazinamide is Independent of trans-Translation and RpsA
Nicholas A. Dillon et al.
SCIENTIFIC REPORTS (2017)
Uncoupling Environmental pH and Intrabacterial Acidification from Pyrazinamide Susceptibility in Mycobacterium tuberculosis
Nicholas D. Peterson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Pantothenate and Pantetheine Antagonize the Antitubercular Activity of Pyrazinamide
Nicholas A. Dillon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis
Wanliang Shi et al.
EMERGING MICROBES & INFECTIONS (2014)
Mutations in panD encoding aspartate decarboxylase are associated with pyrazinamide resistance in Mycobacterium tuberculosis
Shuo Zhang et al.
EMERGING MICROBES & INFECTIONS (2013)
Validation of Drug-Like Inhibitors against Mycobacterium Tuberculosis L-Aspartate α-Decarboxylase Using Nuclear Magnetic Resonance (1H NMR)
Reetu Sharma et al.
PLOS ONE (2012)
LigPlot+: Multiple Ligand-Protein Interaction Diagrams for Drug Discovery
Roman A. Laskowski et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2011)
Pyrazinamide Inhibits Trans-Translation in Mycobacterium tuberculosis
Wanliang Shi et al.
SCIENCE (2011)
Label-Free Detection of Biomolecular Interactions Using BioLayer Interferometry for Kinetic Characterization
Joy Concepcion et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2009)
Phaser crystallographic software
Airlie J. McCoy et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2007)
Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes
Richard A. Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
HKL-3000:: the integration of data reduction and structure solution -: from diffraction images to an initial model in minutes
Wladek Minor et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2006)
Crystal structure of the Schiff base intermediate prior to decarboxylation in the catalytic cycle of aspartate α-decarboxylase
B Lee et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid
Y Zhang et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis
VK Sambandamurthy et al.
NATURE MEDICINE (2002)
Expression, purification, and biochemical characterization of Mycobacterium tuberculosis aspartate decarboxylase, PanD
S Chopra et al.
PROTEIN EXPRESSION AND PURIFICATION (2002)
Effects of pyrazinamide on fatty acid synthesis by whole mycobacterial cells and purified fatty acid synthase I
HI Boshoff et al.
JOURNAL OF BACTERIOLOGY (2002)
Conditions that may affect the results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamide
Y Zhang et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2002)
Pyrazinamide inhibits the eukaryotic-like fatty acid synthetase I (FASI) of Mycobacterium tuberculosis
O Zimhony et al.
NATURE MEDICINE (2000)
分享论文
